Data Monitoring in the AIDS Clinical Trials Group Study #981: Conflicting Interim Results
Dianne M. Finkelstein
Additional contact information
Dianne M. Finkelstein: Massachusetts General Hospital, Biostatistics Center
Chapter Case 6 in Data Monitoring in Clinical Trials, 2006, pp 109-117 from Springer
Abstract:
Abstract In 1989, the NIH sponsored AIDS Clinical Trials Group (ACTG) mounted a large prospective randomized trial (known as ACTG 981) to compare fluconazole (200 mg daily) with clotrimazole lozenges (10mg, five times daily) for prevention of invasive fungal infections in patients with advanced HIV disease. At the fourth DSMB review of the study in November 1992, the patients on fluconazole had a significantly lower risk of invasive, serious and superficial fungal infections, but a higher mortality rate than the patients on clotrimazole. The DSMB recommended keeping the study open in spite of the fact that a boundary had been crossed for the primary endpoint. The final analysis of this study, published in the New England Journal of Medicine, reported that the trial gave evidence of the superiority of fluconazole in preventing the most serious fungal infections, but did not show an advantage in reducing overall mortality, thus vindicating the recommendations of the DSMB to keep the trial open until the planned follow-up had been completed. This paper is a review of the DSMB process for this study, and how the Board dealt with the challenges of interpretation of apparently contradictory evidence on treatment efficacy.
Keywords: Fungal Infection; Invasive Fungal Infection; Cryptococcal Meningitis; Case Study Approach; Data Safety Monitoring Board (search for similar items in EconPapers)
Date: 2006
References: Add references at CitEc
Citations:
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-0-387-30107-5_10
Ordering information: This item can be ordered from
http://www.springer.com/9780387301075
DOI: 10.1007/0-387-30107-0_10
Access Statistics for this chapter
More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().